Literature DB >> 1883227

Changes in pulmonary surfactant during bacterial pneumonia.

K A Brogden1.   

Abstract

In pneumonia, bacteria induce changes in pulmonary surfactant. These changes are mediated by bacteria directly on secreted surfactant or indirectly through pulmonary type II epithelial cells. The bacterial component most likely responsible is endotoxin since gram-negative bacteria more often induce these changes than gram-positive bacteria. Also, endotoxin and gram-negative bacteria induce similar changes in surfactant. The interaction of bacteria or endotoxin with secreted surfactant results in changes in the physical (i.e. density and surface tension) properties of surfactant. In addition, gram-negative bacteria or endotoxin can injure type II epithelial cells causing them to produce abnormal quantities of surfactant, abnormal concentrations of phospholipids in surfactant, and abnormal compositions (i.e. type and saturation of fatty acids) of PC. The L/S ratio, the concentration of PG, and the amount of palmitic acid in PC are all significantly lower. The changes in surfactant have a deleterious effect on lung function characterized by significant decreases in total lung capacity, static compliance, diffusing capacity, and arterial PO2 and a significant increase in mean pulmonary arterial pressure. Also decreased concentrations of surfactant or an altered surfactant composition can result in the anatomic changes commonly seen in pneumonia such as pulmonary edema, hemorrhage, and atelectasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883227     DOI: 10.1007/bf00583673

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  36 in total

1.  Enterobacter agglomerans lipopolysaccharide-induced changes in pulmonary surfactant as a factor in the pathogenesis of byssinosis.

Authors:  A J DeLucca; K A Brogden; R Engen
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

2.  Internalization of pulmonary surfactant into lamellar bodies of cultured rat pulmonary type II cells.

Authors:  M Kalina; R Socher
Journal:  J Histochem Cytochem       Date:  1990-04       Impact factor: 2.479

Review 3.  A proposed nomenclature for pulmonary surfactant-associated proteins.

Authors:  F Possmayer
Journal:  Am Rev Respir Dis       Date:  1988-10

Review 4.  The pulmonary surfactant system: biochemical aspects and functional significance.

Authors:  L M Van Golde; J J Batenburg; B Robertson
Journal:  Physiol Rev       Date:  1988-04       Impact factor: 37.312

5.  Profiles of type-II pneumocytes in rats inoculated intratracheally with bacterial lipopolysaccharide.

Authors:  A Lopez; M Albassam; S Yong; A Sharma; L E Lillie; M G Prior
Journal:  Am J Vet Res       Date:  1987-10       Impact factor: 1.156

6.  Interaction of a rat lung lectin with the exopolysaccharides of Pseudomonas aeruginosa.

Authors:  H A McArthur; H Ceri
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  O2- and pneumonia-induced lung injury. I. Pathological and morphometric studies.

Authors:  J J Coalson; R J King; V T Winter; T J Prihoda; A R Anzueto; J I Peters; W G Johanson
Journal:  J Appl Physiol (1985)       Date:  1989-07

8.  Influence of E. coli lipopolysaccharide binding to rat alveolar type II cells on their functional properties.

Authors:  F M Aracil; M A Bosch; A M Municio
Journal:  Mol Cell Biochem       Date:  1985-09       Impact factor: 3.396

9.  Lung surfactant phospholipids in different animal species.

Authors:  S A Shelley; J E Paciga; J U Balis
Journal:  Lipids       Date:  1984-11       Impact factor: 1.880

10.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

Authors:  M Hallman; R Spragg; J H Harrell; K M Moser; L Gluck
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

View more
  7 in total

1.  Involvement of calcium in the stimulation of phosphatidylcholine secretion in primary cultures of rat type II pneumocytes by Escherichia coli lipopolysaccharide.

Authors:  E Benito; M T Portolés; M A Bosch
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

2.  Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.

Authors:  Matthew J Wargo; Maegan J Gross; Sathish Rajamani; Jenna L Allard; Lennart K A Lundblad; Gilman B Allen; Michael L Vasil; Laurie W Leclair; Deborah A Hogan
Journal:  Am J Respir Crit Care Med       Date:  2011-05-11       Impact factor: 21.405

3.  Fatty acid intake and the risk of community-acquired pneumonia in U.S. women.

Authors:  Michael Alperovich; Mark I Neuman; Walter C Willett; Gary C Curhan
Journal:  Nutrition       Date:  2007-01-22       Impact factor: 4.008

4.  Lipid peroxidation of lung surfactant in experimental neonatal group B streptococcal pneumonia.

Authors:  R K L Bouhafs; C Jarstrand; B Robertson
Journal:  Lung       Date:  2004       Impact factor: 2.584

5.  Agglutination of lung surfactant with glucan.

Authors:  A J De Lucca; K A Brogden; A D French
Journal:  Br J Ind Med       Date:  1992-11

Review 6.  Fundamentals of aerosol therapy in critical care.

Authors:  Jayesh Dhanani; John F Fraser; Hak-Kim Chan; Jordi Rello; Jeremy Cohen; Jason A Roberts
Journal:  Crit Care       Date:  2016-10-07       Impact factor: 9.097

7.  The Perturbation of Pulmonary Surfactant by Bacterial Lipopolysaccharide and Its Reversal by Polymyxin B: Function and Structure.

Authors:  Maros Kolomaznik; Gilda Liskayova; Nina Kanjakova; Lukas Hubcik; Daniela Uhrikova; Andrea Calkovska
Journal:  Int J Mol Sci       Date:  2018-07-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.